Normal baseline cardiac ejection fraction >= %
Ejection fraction of >= %
Patients with angina, a cardiac ejection fraction < %, or ischemic heart disease are not eligible
All included patients must have normal cardiac function as defined by an ejection fraction of >= % and no decrease in wall motion by echocardiogram
All included subjects must have normal cardiac function as defined by an ejection fraction of > % by echocardiogram
Cardiac ejection fraction < % (or, if unable to obtain ejection fraction, shortening fraction < %) on multiple-gated acquisition (MUGA) scan or cardiac echocardiogram (echo), symptomatic coronary artery disease, or other cardiac failure requiring therapy; patients with a history of, or current cardiac disease should be evaluated with appropriate cardiac studies and/or cardiology consult; patients with a shortening fraction of < % must be seen by cardiology for approval
Cardiac function: Ejection fraction > %
Ejection Fraction >= %
Normal ejection fraction (echocardiogram [ECHO]) >= % (if a range is given then the upper value of the range will be used) or cardiac MRI
Ejection fraction >= %
Cardiac ejection fraction < %
Cardiac ejection fraction < %
Cardiac ejection fraction >= % as determined by screening echocardiogram
Baseline cardiac ejection fraction must be >=  %.
Cardiac ejection fraction of >= %
No uncontrolled or severe cardiac disease. Baseline ejection fraction (by nuclear imaging or echocardiography) must by ? %
Cardiac ejection fraction of >= %
Known cardiac ejection fraction of > or = % within the past  months
Ejection fraction > %
History of congestive heart failure and cardiac ejection fraction =< %
Cardiac ejection fraction >= %
Cardiac ejection fraction at rest must be >= %
Cardiac ejection fraction >= % by echocardiogram (ECHO)
Ejection fraction less than % by echocardiography
Participants must have normal cardiac ejection fraction (per label, as defined as institutional normal)
Ejection fraction >= %
Have adequate cardiac function as assessed by echocardiogram, with an ejection fraction (EF) > %
Significant cardiovascular abnormalities as defined by any one of the following: congestive heart failure, clinically significant hypotension, symptomatic coronary artery disease, or a documented ejection fraction of < %; any patient with an ejection fraction (EF) of -% must receive clearance by a cardiologist to be eligible for the trial
Cardiac ejection fraction greater than or equal to % by echocardiogram
Cardiac ejection fraction (EF) < %
Baseline ejection fraction must be >= %
Baseline test of ejection fraction must be >= %
Normal cardiac function must be documented within  days prior to registration; result of ejection fraction must be above the normal limit of the institution
Ejection fraction < %, or uncontrolled cardiac failure
Ejection fraction > %
Known cardiac ejection fraction < %
Known cardiac ejection fraction of >= % within the past  months
Patients with significant lung disease, an ejection fraction less than %, or a resting heart rate less than /min will not be enrolled
Cardiac ejection fraction (EF) >= % by -dimensional echocardiogram (D-ECHO) within  months of study entry (or within  month if received chemotherapy within the past  months)
Ejection fraction >= %
Ejection fraction >= % on echocardiogram
Cardiac ejection fraction =< %
Adequate cardiac reserve with a cardiac ejection fraction within the lower limit of facility normal by MUGA, or % by echocardiogram
Ejection fraction >= %
Cardiac: ejection fraction > %
Clinically significant heart disorders including an ejection fraction of < %
Cardiac ejection fraction ? %. If between -% a cardiology consult is required
Cardiac ejection fraction > %
Cardiac ejection fraction less than %
Known cardiac ejection fraction of >= % within the past  months
Cardiac ejection fraction >= % or within institutional normal limits; a nuclear medicine gated blood pool examination is preferred; a two-dimensional (-D) echocardiogram (ECHO) scan is acceptable if a calculated ejection fraction is obtained and follow-up measurement of the cardiac ejection fraction will also be performed by echocardiography; measurement of cardiac ejection fraction should be within two weeks prior to receiving treatment\r\n* NOTE: when a multi gated acquisition scan (MUGA) or echocardiogram cannot be obtained due to weekend or holiday, then patients may be enrolled provided there is no history of significant cardiovascular disease and a measurement of cardiac ejection fraction will be performed within  days of study enrollment
Patients must have a cardiac ejection fraction of >= %, or within institutional normal limits; a nuclear medicine gated blood pool examination is preferred; a -D ECHO scan is acceptable if a calculated ejection fraction is obtained and follow-up measurement of the cardiac ejection fraction will also be performed by echocardiography; measurement of cardiac ejection fraction should be within two weeks prior to allogeneic transplantation
Cardiac ejection fraction >= %
Adequate cardiac reserve (ejection fraction [EF] >= %)
Cardiac ejection fraction has to be >= %
Ejection fraction >= %
Cardiac ejection fraction < % or, if unable to obtain ejection fraction, shortening fraction of < %) on multi-gated acquisition (MUGA) scan or cardiac echo, symptomatic coronary artery disease, other cardiac failure requiring therapy; patients with a history of, or current cardiac disease should be evaluated with appropriate cardiac studies and/or cardiology consult; patients with a shortening fraction < % may be enrolled if approved by a cardiologist
Ejection fraction must be >= %
Cardiac ejection fraction >= %
Pre-existing known cardiovascular abnormalities as defined by any one of the following: \t\r\n* Congestive heart failure \r\n* Clinically significant hypotension \r\n* Cardiac ischemia, or symptoms of coronary artery disease\r\n* Presence of cardiac arrhythmias on electrocardiogram (EKG) requiring drug therapy\r\n* Ejection fraction < % (echocardiogram or MUGA), although any patient with an ejection fraction between -% must receive clearance by a cardiologist to be eligible for Step II of the trial
Pre-existing known cardiovascular abnormalities as defined by any one of the following: \t\r\n* Congestive heart failure \r\n* Clinically significant hypotension \r\n* Cardiac ischemia, or symptoms of coronary artery disease\r\n* Presence of cardiac arrhythmias on EKG requiring drug therapy\r\n* Ejection fraction < %, although any patient with an ejection fraction between -% must receive clearance by a cardiologist to be eligible for Step II of this trial
Cardiac ejection fraction ? % and no clinically significant ECG findings
Cardiac ejection fraction >= %
Normal cardiac ejection fraction of > %
Ejection fraction > % on echocardiogram
Cardiac history of CHF requiring treatment or Ejection Fraction less than or equal to % or chronic stable angina;
Cardiac ejection fraction < %
Ejection fraction >= % by echocardiogram
Ejection fraction >= %
Cardiac ejection fraction >= %
Cardiac ejection fraction > %
Ejection fraction > %
Cardiac ejection fraction >= %
Cardiac ejection fraction ? % by echocardiography or MUGA
Ejection fraction >= % (within  weeks prior to study enrollment)
Ejection fraction (EF) < % or uncontrolled cardiac failure
Ejection fraction (EF) >= %
Cardiac ejection fraction > %
Cardiac ejection fraction < %; ejection fraction is required if age >  years or there is a history of prior transplant, anthracycline exposure or history of cardiac disease; and poorly controlled hypertension despite multiple antihypertensives
Cardiac ejection fraction (EF) < % on multi-gated acquisition (MUGA) scan or cardiac echocardiogram (echo) (or if unable to obtain ejection fraction, shortening fraction of < %); patients with active or a history of cardiac disease should be evaluated with appropriate cardiac studies and/or consult; ejection fraction is required if age >  years or there is a history of anthracyclines or history of cardiac disease; patients with a shortening fraction < % may be enrolled if approved by a cardiologist
Known ejection fraction < %.
Ejection fraction equal or above %
Cardiac ejection fraction within normal limits as measured by echocardiogram
Patients with poor cardiac function defined as an ejection fraction (EF) < % are excluded
Ejection fraction >= % by echocardiogram
Ejection fraction < %
No history of serious cardiac arrhythmia or ejection fraction (EF) < %
Known heart failure (ejection fraction [EF] < %)
Cardiac ejection fraction (EF) >= % by -dimensional echocardiogram (D-Echo)
Ejection fraction (EF) >= %
Cardiac ejection fraction >= % without evidence of congestive heart failure (CHF)
Patients with poor cardiac function as defined by an ejection fraction < % are excluded (only for patients enrolled on second phase of protocol for leukapheresis)
Abnormal baseline cardiac function defined as an ejection fraction of less than %
Cardiac ejection fraction <  (using motion [M]-Mode if assessment is done by echocardiogram [ECHO])
Cardiac ejection fraction >= %
Cardiac ejection fraction > %
Adequate cardiac function defined as an ejection fraction of at least %
Ejection fraction at rest >= %
Cardiac function: ejection fraction > %
Cardiac function: Ejection fraction at rest ? %
Patients must have normal cardiac ejection fraction
Participants must have normal cardiac ejection fraction
Cardiac ejection fraction >% (by echocardiogram or MUGA) within  days of enrollment
The patients estimated cardiac ejection fraction is < % by echocardiogram or MUGA
Patient has a cardiac ejection fraction <%